Last updated on November 2017

Irritable Bowel Syndrome - Diarrhea Predominant


Brief description of study

Irritable Bowel Syndrome - Diarrhea Predominant

Detailed Study Description

Do you frequently get cramps, discomfort, and diarrhea? Do the symptoms seem to come and go randomly and aren’t something you can pin down to a specific food, drink, medication, or menstrual cycles? You could be one of the estimated 20% of Americans who have Irritable Bowel Syndrome.

This study is evaluating a brand new medication for the treatment of IBS. The medication works by staying in the intestinal track and slowing down the speed the bowels move. It also self regulates to prevent medication related constipation. Current use of medications does not exclude you from participating.

Benefits Include:

  • Receive up to $600.00 in compensation.
  • Study is 1 year long.
  • All study-related care is provided at no cost.
  • Insurance is not needed to participate.
  • No cost to participate.
  • Continue to see your own doctor.
  • Completely voluntary, you can withdraw at any time for any reason.

Patient Inclusion Criteria:

  • Be 18 to 80 years of age.
  • Have experienced bowel pain, discomfort, bloating, or diarrhea at least 3 days per month for the last 6 months.

Patient Exclusion Criteria:

  • Have been diagnosed with Celiac, Crohn’s, Lactose Intolerance, Gluten Intolerance, or Inflammatory Bowel Disease.

Clinical Study Identifier: TX4656

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )